Venetoclax and Ibrutinib in Treating in Participants With Chronic Lymphocytic Leukemia and Ibrutinib Resistance Mutations
about
Venetoclax and Ibrutinib in Treating in Participants With Chronic Lymphocytic Leukemia and Ibrutinib Resistance Mutations
description
clinical trial
@en
klinisch onderzoek
@nl
name
Venetoclax and Ibrutinib in Tr ...... Ibrutinib Resistance Mutations
@en
type
label
Venetoclax and Ibrutinib in Tr ...... Ibrutinib Resistance Mutations
@en
prefLabel
Venetoclax and Ibrutinib in Tr ...... Ibrutinib Resistance Mutations
@en
P1050
P1476
Phase 2 Study of Venetoclax Ad ...... ib Resistance Mutations in CLL
@en
P3098
NCT03513562
P4844
P580
2019-02-27T00:00:00Z
P582
2021-02-28T00:00:00Z